PK Study to Assess Drug-drug Interaction and QTc Between Sitravatinib and a Cocktail of Substrates
Clinical trial NCT04887194 · COMPLETED
Trial details
- NCT number
- NCT04887194
- Sponsor
- Mirati Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-08
- Primary completion
- 2022-12-22
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.